Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and pharmacodynamic study of tenofovir 1% gel for HIV prevention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Tenofovir 1% Gel (tenofovir)

Snippet

Sponsor: CONRAD | Conditions: Prevention | Phase 1 | Status: COMPLETED